cyclopentenone has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Cui, W; Fang, F; He, S; Huang, C; Liu, F; Naman, CB; Shentu, J; Sun, C; Wang, M; Wang, Q; Wang, Y; Xu, S; Yan, S; Zhao, J | 1 |
| Blackwell, TS; Brooks, JD; Brunoldi, E; Joo, M; McLaughlin, B; Milne, GL; Montine, TJ; Morrow, JD; Musiek, ES; Porta, A; Vidari, G; Zanoni, G | 1 |
2 other study(ies) available for cyclopentenone and Alzheimer Disease
| Article | Year |
|---|---|
5-Hydroxycyclopenicillone Inhibits β-Amyloid Oligomerization and Produces Anti-β-Amyloid Neuroprotective Effects In Vitro.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Cyclopentanes; Fungi; Humans; Molecular Dynamics Simulation; Neurons; Neuroprotective Agents | 2017 |
Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid.
Topics: Alzheimer Disease; Animals; Cell Line; Cyclooxygenase 2; Cyclopentanes; Docosahexaenoic Acids; Electrons; Humans; I-kappa B Kinase; Inflammation; Lipid Peroxidation; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; NF-kappa B; Nitric Oxide Synthase Type II; Signal Transduction | 2008 |